Right Ventricular Contractility Reserve Following Repair of Tetralogy of Fallot (TOF-Cond)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background: Residual pulmonary regurgitation following repair of tetralogy of Fallot, in particular the use of a transannular patch, has been shown to correlate with the development of right ventricular dysfunction. Optimal timing of pulmonary valve replacement, therefore, is important to preserve right ventricular function. Several recent studies suggested that a threshold of right ventricular end-diastolic volume for intervention, in order to preserve the likelihood of adequate reverse remodeling, is in the region of 150 to 200 ml/m2 body surface area. However, there is evidence that right ventricular function does not always recover following pulmonary valve replacement even if the end-diastolic volume is below this cut-off.
In addition, previous studies suggested that early dysfunction may be present before symptoms occur. However, early dysfunction is difficult to assess.
Methods: Analysis of right ventricular function by pressure-volume loops has been extensively evaluated in experimental studies and is generally considered the optimal way to quantify right ventricular function.
By recording a family of pressure-volume loops during reduction of preload, achieved by temporary balloon occlusion of the inferior caval vein, the contractility can be calculated by the slope of the endsystolic pressure-volume relation (elastance). Changes of contractility following dobutamine infusion could be noted by changes of elastance. The increase of the slope during dobutamine demonstrates the contractility reserve of the right ventricle.
Purpose: To evaluate the right ventricular contractility reserve to determine early ventricular dysfunction after repair of tetralogy of Fallot.
| Condition | Intervention |
|---|---|
|
Right Ventricular Dysfunction |
Other: dobutamine |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Evaluation of Right Ventricular Contractility Reserve Function During Dobutamine Stress in Patients Following Surgical Repair of Tetralogy of Fallot |
- Percentage of change of the maximal elastance (slope of the endsystolic pressure-volume relation)of the right ventricle following dobutamine infusion [ Time Frame: 10 minutes after starting dobutamine infusion ] [ Designated as safety issue: No ]
- Brain natriuretic peptide [ Time Frame: at cath study ] [ Designated as safety issue: No ]
- RV enddiastolic volume index (by MRI) [ Time Frame: within the last 6 months before study ] [ Designated as safety issue: No ]
| Enrollment: | 16 |
| Study Start Date: | October 2007 |
| Study Completion Date: | September 2008 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 |
Other: dobutamine
dobutamine stress (10 µg/kg/min) for 10 minutes during heart catheterization
|
Eligibility| Ages Eligible for Study: | 4 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Corrected tetralogy of Fallot or other surgery with involvement of the pulmonary valve, chronic pulmonary regurgitation, dilated right ventricle
- Patient's age > 4 years
- Routine cardiac catheterization clinically indicated for deciding therapeutic treatment
- Informed assent/consent of patients/parent.
Exclusion Criteria:
- Pregnancy/breast feeding, women of child-bearing age without contraception.
- Present participation, and/or participation in a clinical study during the last 4 weeks.
- Illnesses or malfunctions, which exclude a participation in this study after decision of the investigating physician.
- Other medical, psychological or social circumstances which complicate a regular participation in the study, and/or increase the risk for the patients themselves.
Contacts and Locations| Germany | |
| Department of Pediatric Cardiology, University Childrens Hospital | |
| Tuebingen, Baden-Wuerttemberg, Germany, 72076 | |
| Principal Investigator: | Michael Hofbeck, MD | University Childrens Hospital, Department of Pediatric Cardiology |
More Information
No publications provided
| Responsible Party: | Professor Dr. Michael Hofbeck, University Children's Hospital, Tuebingen, Germany |
| ClinicalTrials.gov Identifier: | NCT00557934 History of Changes |
| Other Study ID Numbers: | Cond-07-1 |
| Study First Received: | November 13, 2007 |
| Last Updated: | September 17, 2008 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by University Hospital Tuebingen:
|
tetralogy of Fallot right ventricular dysfunction pulmonary insufficiency |
pulmonary valve replacement pressure-volume loops long-term follow-up in tetralogy of Fallot |
Additional relevant MeSH terms:
|
Tetralogy of Fallot Ventricular Dysfunction, Right Ventricular Dysfunction Heart Defects, Congenital Cardiovascular Abnormalities Cardiovascular Diseases Heart Diseases Congenital Abnormalities Dobutamine Cardiotonic Agents Cardiovascular Agents Therapeutic Uses |
Pharmacologic Actions Sympathomimetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Adrenergic beta-1 Receptor Agonists Adrenergic beta-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Protective Agents |
ClinicalTrials.gov processed this record on June 17, 2013